Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05650853
Other study ID # 2022-A01594-39
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 12, 2022
Est. completion date January 9, 2023

Study information

Verified date January 2023
Source Clinique Pasteur
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Ejaculatory dysfunctions (ED) are an important cause of postoperative dissatisfaction, which lead to a decrease in the intensity of orgasms in 50% of patients. ED is a cause for concern for almost a third of patients who need surgery. Surgical techniques have been developed to limit the occurrence of postoperative ED, but their results remain heterogeneous. There are very few studies on the biomechanical anatomy of ejaculation. Ejaculation is a complex phenomenon involving different structures and in particular the Veru Montanum. This is the key element in the emission of ejaculate within the prostatic urethra. In addition, there is a structure located in the resection zone of the prostate adenoma. It has therefore been suggested that its resection was a primary source of ED. A single observational study carried out in by Gil Vernet et al in 1994 evaluated on a single healthy 18-year-old volunteer the ejaculatory mechanism of expulsion using an endorectal probe recording the movements of the prostate, the bladder neck and of the proximal urethra during ejaculation. A contemporary study of the biomechanics of the ejaculatory expulsion phase could confirm and improve understanding of the involvement of anatomical structures. The results of our study aim to adapt surgical techniques aimed at limiting the risk of postoperative ED.


Recruitment information / eligibility

Status Completed
Enrollment 3
Est. completion date January 9, 2023
Est. primary completion date January 9, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - Affiliated subject or beneficiary of a social security scheme - Subject agreeing to participate and having signed the free, informed consent. Exclusion Criteria: - Subject with ejaculatory dysfunction - Subject with urinary dysfunction - History of urinary or penile surgery - Subject with untreated urinary tract infection - History of chronic prostatitis - Pathology making it impossible to introduce the endorectal probe or the ureteroscope - History of colorectal inflammatory disease - Recent intake (within 30 days) of drugs known to interfere with ejaculation - History of intolerance or allergy to any of the drugs used in the study - Subject participating in another clinical study - Adults under guardianship, curatorship or other legal protection; deprived of liberty by judicial or administrative decision; Hospitalized without consent.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Transrectal ultrasound
Examinations for observation of the pre, per and post-ejaculatory phases
Urethroscopy
Examinations for observation of the pre, per and post-ejaculatory phases

Locations

Country Name City State
France Clinique Pasteur Toulouse

Sponsors (1)

Lead Sponsor Collaborator
Clinique Pasteur

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Peri-urethral muscle contraction Qualitative description of peri-urethral muscle contraction according to ultrasound videos analysis At Day 0
Primary Urethra, bladder neck and prostate movements Qualitative description of movements of the urethra, bladder neck and prostate according to ultrasound videos analysis At Day 0
Primary Sperm flow within the prostatic urethra Qualitative description of sperm flow within the prostatic urethra according to ultrasound videos analysis At Day 0
Primary Spermatic fluid via the ejaculatory ducts Qualitative description of the expulsion and flow of spermatic fluid via the ejaculatory ducts according to urethroscopy videos analysis At Day 6
Primary Veru montanum mobility and urethral contraction. Qualitative description of veru montanum mobility and urethral contraction according to urethroscopy videos analysis At Day 6
See also
  Status Clinical Trial Phase
Recruiting NCT05826691 - Benign Prostate Surgery and QOL and Sexual Function
Recruiting NCT03176017 - Ejaculatory Sparing Transurethral Incision Of The Prostate (ES-TUIP) Versus Conventional TUIP N/A
Not yet recruiting NCT05914519 - Outcomes and Efficacy of Ejaculatory Preserving Transurethral Resection of Prostate N/A
Recruiting NCT05370651 - Emsella Chair vs Sham for Male Sexual Dysfunction N/A
Completed NCT01419236 - A Study of Ejaculatory Dysfunction in Men With Low Testosterone Levels Phase 2